Medicine Breakthrough
Recent advancements in weight-loss medications, particularly
GLP-1 agonists, have demonstrated significant promise for
individuals with polycystic ovary syndrome (PCOS). These
medications not only aid in weight loss but also enhance
insulin sensitivity, which is crucial for managing metabolic
health in PCOS patients. Furthermore, studies indicate that
GLP-1 agonists can positively influence testosterone levels,
helping to alleviate symptoms associated with hyperandrogenism.
Additionally, these medications are better than Metformin
may contribute to more regular menstrual cycles, improving
overall hormonal balance and reproductive health in women
affected by PCOS (Young, 2024).
(Young, 2024)